News & Updates

Patients with chronic obstructive pulmonary disorder (COPD) face a heightened risk of adverse cardiovascular events following moderate or severe exacerbations, according to a study.

Redoing surgical mitral valve replacement (SMVR) or undergoing transcatheter mitral valve replacement (TMVR) in patients with failed prostheses results in similar 3-year outcomes, reports a recent study. TMVR, however, initially displays a lower risk of major adverse cardiovascular events (MACE), but this risk increases after 6 months.

Children who regularly consume wholegrain oats and rye (WG) benefit from lower serum low-density lipoprotein (LDL) cholesterol and triacylglycerol, modulated taxa, and higher beneficial metabolites, according to a recent study.

Patients who received direct oral anticoagulants (DOACs) following transcatheter mitral valve replacement (TMVR) seem to have a lower risk of bleeding complications and shorter length of hospital stay, with no significant increase in the risk of thrombotic events, than those treated with vitamin K antagonists (VKAs), a study has shown.